Tech Company Financing Transactions
Gallant Funding Round
Bling Capital, Bold Capital Partners and Maveron participated in a $11 million funding round for Gallant. The round was announced on 10/25/2019.
Transaction Overview
Company Name
Announced On
10/25/2019
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12130 Millennium Dr.
Los Angeles, CA 90094
USA
Los Angeles, CA 90094
USA
Phone
Website
Email Address
Overview
The Gallant team is a collective of respected veterinarians, scientists, and some unbelievably dedicated entrepreneurs. Our work is the result of over 100 years of regenerative medicine experience, and a commitment to invest millions into the future of stem cell therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Aaron Hirschhorn
Chief Medical Officer
Shelly Zacharias
President
Linda Black
Browse more venture capital transactions:
Prev: 10/25/2019: Bryn Pharma venture capital transaction
Next: 10/27/2019: Taskade venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs